Venture capital firm profile
N1 (Nation 1)
N1 invests in early-stage artificial intelligence, healthcare and frontier-technology companies across Europe and the United States, combining capital with operator support and international connections.

Europe
United States
Seed
Typical first investment: USD 100,000–1 million, not stated hard limits. Equity percentage and founder fees are not disclosed. SFDR disclosure describes management fees paid from fund commitments/invested capital; these are not represented as startup charges. The funds do not currently integrate sustainability risks or consider principal adverse impacts.
AI & Machine Learning, Healthcare & Life Sciences
Europe
Sources checked
United States
Sources checked
Seed
Sources checked
Typical first investment: USD 100,000–1 million, not stated hard limits. Equity percentage and founder fees are not disclosed. SFDR disclosure describes management fees paid from fund commitments/invested capital; these are not represented as startup charges. The funds do not currently integrate sustainability risks or consider principal adverse impacts.
Sources checked
AI & Machine Learning
As of
Sources checked
Healthcare & Life Sciences
As of
Sources checked
N1 combines startup investment with operational guidance and introductions for international expansion. Its current portfolio includes Novoflow, Paratus Health and Superglue; founders should confirm investment structure and costs directly because detailed company financing terms are not published.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
AI & Machine Learning · Investment sectors
As of 2026-11-14
N1 (Nation 1) official sourceN1 (Nation 1) official sourceHealthcare & Life Sciences · Investment sectors
As of 2026-11-14
N1 (Nation 1) official sourceN1 (Nation 1) official sourceLoading recent changes…